Fibronectin glomerulopathy (Q44653): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
A glomerulopatia por fibronectina é uma doença renal hereditária rara na qual depósitos de fibronectina (FN1) são observados no mesângio e no espaço subendotelial. O quadro clínico é caracterizado por proteinúria, acidose tubular renal tipo IV, hematúria microscópica e hipertensão que pode levar à insuficiência renal em estágio terminal da segunda à sexta década de vida. Esta doença pode estar associada a mutações no gene FN1. | |||
| description / en | description / en | ||
Fibronectin glomerulopathy is a rare hereditary kidney disease in which fibronectin (FN1) deposits are seen in the mesangium and subendothelial space. The clinical picture is characterised by proteinuria, type IV renal tubular acidosis, microscopic haematuria and hypertension that may lead to end-stage renal failure in the second to sixth decade of life. This disease may be associated with mutations in the FN1 gene. | |||
Revision as of 12:13, 13 August 2026
Fibronectin glomerulopathy is a rare hereditary kidney disease in which fibronectin (FN1) deposits are seen in the mesangium and subendothelial space. The clinical picture is characterised by proteinuria, type IV renal tubular acidosis, microscopic haematuria and hypertension that may lead to end-stage renal failure in the second to sixth decade of life. This disease may be associated with mutations in the FN1 gene.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | MF81 |
||
| English | Fibronectin glomerulopathy |
Fibronectin glomerulopathy is a rare hereditary kidney disease in which fibronectin (FN1) deposits are seen in the mesangium and subendothelial space. The clinical picture is characterised by proteinuria, type IV renal tubular acidosis, microscopic haematuria and hypertension that may lead to end-stage renal failure in the second to sixth decade of life. This disease may be associated with mutations in the FN1 gene. |
